1. Pink Sheet
  2. >>Geography

Korea’s Clinical Trial Approvals Up 10%, But Still Below Pandemic Peak

Gaining Favor As Study Location

 
• By Jung Won Shin

South Korea’s clinical trial approvals rebounded in 2023, but remained lower than the peak levels in 2020-21 amid then robust R&D activity related to COVID-19. Last year's tally showed a mix of single-country and multinational trials and reflected the ongoing dominance of oncology in industry pipelines.

clinical trial
Four Major APAC Countries See Higher Than Average Rise In Clinical Study Approvals • Source: Shutterstock

South Korea’s Ministry of Food and Drug Safety (MFDS) issued approvals for the conduct of 783 clinical trials over the course of 2023, up 10.1% from the previous year, led by an increase in work in oncology, CNS and gastrointestinal disorders.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

More from Asia